Alzheimer’s Society is delighted to welcome Dr Richard Oakley to our Research and Influencing team as Head of Research. In this interview, we hear from Richard, discussing the challenges and opportunities ahead and what he’s excited about in dementia research.
Richard completed a PhD in supramolecular chemistry at the Bristol University, building complex functional molecules for drug delivery or electronics, before moving to the EPFL in Lausanne to do a two-year post-doc in tissue engineering, focusing on wound rejuvenation after brain injury or heart disease. After his post-doc, he made the transition away from the lab and moved to Cancer Research UK as their Senior Research Funding Manager.
Read the interview in full here – https://www.alzheimers.org.uk/for-researchers/new-head-of-research-dr-richard-oakley
[…] and their families, [who need] to be provided with the most up-to-date information,” explained Dr. Richard Oakley, head of research at Alzheimer’s Society, in the […]
[…] Dr Richard Oakley of the Alzheimer's Society, which part-funded the research, commented that 'Epigenetics is a flourishing area of dementia research. It's now important to delve into the specific impact of these epigenetic changes and the associated genes on the changes in the brains of people with Alzheimer's disease. This work is in early stages but breakthroughs in research begins with work like this, and it brings us a step closer to developing new treatments for Alzheimer's disease.' […]